ArticleFrontiers in oncology2025

Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Ling Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.